Doma perpetual supports pacira's new $300 million share repurchase authorization as a meaningful step to enhance value for shareholders

Doma perpetual believes pacira's stock is undervalued, presenting an opportunity to execute the largest buyback in the company's history miami , april 21, 2025 /prnewswire/ -- doma perpetual capital management llc (collectively with its affiliates, "doma perpetual" or "we") is a fundamentals-based, value-oriented asset management firm which beneficially owns approximately 4.2% of the outstanding shares of common stock of pacira biosciences, inc. (nasdaq:  pcrx ) ("pacira" or the "company"). following constructive engagement with pacira, doma perpetual believes the company's new capital allocation announcementi represents the board's firm commitment to enhancing shareholder value.
DOMA Ratings Summary
DOMA Quant Ranking